Ruggiero Angelo

107PUBLICATIONS
62CO-AUTHORS
Pharmaceutical delivery technologiesChiropracticEpidemiological modellingCancer diagnosisGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (107)

|Apr 26, 2026
Deucravacitinib in Moderate-to-Severe Plaque Psoriasis: A Real-World Study of Effectiveness and Safety in Clinical Practice.

|Aug 12, 2025
Effectiveness and Safety of Tildrakizumab in Elderly and Frail Elderly Psoriatic Patients Up to 2 years.

Luca Mastorino, Paolo Dapavo, Martina Burlando

|Oct 14, 2024
Impact of tildrakizumab on the quality of life of patients with moderate-to-severe psoriasis: a 36-week prospective monocentric real-life observational study.

Sara Cacciapuoti, Teresa Battista, Luca Potestio

|Sep 14, 2024
Cutaneous Squamous Cell Carcinoma: From Diagnosis to Follow-Up.

Rosita Comune, Angelo Ruggiero, Antonio Portarapillo

|Jun 04, 2024
The role of teledermatology for the long-term management of stable psoriasis treated with biologics: a survey-based study.

Antonio Portarapillo, Valeria Esposito, Matteo Megna

|Jun 04, 2024
Secukinumab for Severe Hidradenitis Suppurativa in a Patient on Haemodialysis: Efficacy and Safety on 300 mg Every 2 Weeks Administration - A Case Report.

Fabrizio Martora, Maria Carmela Annunziata, Luca Potestio

Pageof 18

Frequent Collaborators

49 joint publications

Matteo Megna

47 joint publications

Luca Potestio

40 joint publications

Fabrizio Martora

19 joint publications

Gabriella Fabbrocini